These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [EFFECTIVENESS OF CYTOFLAVIN FOR THE CORRECTION OF COGNITIVE IMPAIRMENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS]. Gatskikh IV; Veselova OF; Brikman IN; Shalda TP; Varygina EL; Kuznetsov MN; Shul'min AV; Petrova MM Eksp Klin Farmakol; 2015; 78(11):21-5. PubMed ID: 27017701 [TBL] [Abstract][Full Text] [Related]
44. [Correction of bioenergetic processes in small intestine during experimental widespread purulent peritonitis]. Kosinets VA Eksp Klin Farmakol; 2012; 75(8):39-43. PubMed ID: 23012995 [TBL] [Abstract][Full Text] [Related]
45. [The structure of psychopathology associated with addictive disorders, against alcohol addiction and the possibility of it's neurometabolic correction in the elderly]. Belov VG; Parfenov IuA; Zaplutanov VA; Khaĭrutdinov DR Adv Gerontol; 2013; 26(4):696-701. PubMed ID: 24738262 [TBL] [Abstract][Full Text] [Related]
47. [The application of combined physiotherapeutic methods for the complex treatment of patients with dyscirculatory encephalopathy]. Shiman AG; Klocheva EG; Kaiumov SF; Shoferova SD; Zhukova MV Vopr Kurortol Fizioter Lech Fiz Kult; 2012; (2):9-12. PubMed ID: 22908466 [TBL] [Abstract][Full Text] [Related]
48. [Dynamics of cognitive disorders in patients with type 2 diabetes mellitus under effect of metabolic therapy]. Gatckikh IV; Petrova MM; Shalda TP; Varygina EL; Kuznetsov MN; Narkevich AN Klin Med (Mosk); 2016; 94(7):533-9. PubMed ID: 30289219 [TBL] [Abstract][Full Text] [Related]
49. [Efficacy of the energy-modifier cytoflavin in the treatment of patients with hypertensive encephalopathy]. Belova LA; Kolotik-Kameneva OIu; Mashin VV; Saprygina LV; Mashin EV Ter Arkh; 2014; 86(9):65-70. PubMed ID: 25518508 [TBL] [Abstract][Full Text] [Related]
50. [Pharmacologic correction of hypoxia in patients with acute cerebral failure due to acute poisoning with carbon monoxide and combustion products]. Shilov VV; Vasil'ev SA; Kuznetsov OA; Batotsyrenov BV; Loladze AT Med Tr Prom Ekol; 2012; (6):22-7. PubMed ID: 22997755 [TBL] [Abstract][Full Text] [Related]
51. [Rationale of application of the drug Cytoflavin in complex treatment of patients with diabetic foot syndrome with mediacalcification arteries]. Mikhaloĭko IIa; Sabadosh RV; Kovalenko AL; Skripko VD Khirurgiia (Mosk); 2014; (12):36-40. PubMed ID: 25589316 [TBL] [Abstract][Full Text] [Related]
52. [Methods for the prevention and treatment of toxico-hypoxic encephalopathy in patients with acute severe poisoning]. Klin Med (Mosk); 2011; 89(6):56-9. PubMed ID: 22420197 [TBL] [Abstract][Full Text] [Related]
53. [Behavioral psychotherapy and citoftavin in the treatment of deforming coxarthrosis in elderly patients]. Zakharov KI; Parfyenov SA; Belov VG; Parfyenov UA; Ershov EV; Sapozhnikov KV; Kovalenko AL; Haritonova TV; Skripko VD Adv Gerontol; 2016; 29(5):816-821. PubMed ID: 28556655 [TBL] [Abstract][Full Text] [Related]
54. [Study cytoflavin dose-dependent effect in the treatment of acute ischemic stroke]. Sazonov IE; Kudinov AA; Fedotova EP Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(2):64-67. PubMed ID: 28374695 [TBL] [Abstract][Full Text] [Related]
55. [Investigation of the antioxidant activity and cardioprotective effect of reamberin and cytoflavin in newborn rats exposed to chronic hemic hypoxia]. Zadnipryanyi IV; Tretyakova OS; Sataeva TP Arkh Patol; 2015; 77(6):39-44. PubMed ID: 26841648 [TBL] [Abstract][Full Text] [Related]
56. [The intraoperative prophylaxis of local ischemical brain damage in neurosurgical patients with cerebral aneurysm]. Savvina IA; Cherebillo VY; Zabrodskaya YM; Petrova AO; Sergeev AV; Paltsev AA; Rutkovskiy RV; Malkhozova AM Khirurgiia (Mosk); 2019; (5):57-63. PubMed ID: 31169820 [TBL] [Abstract][Full Text] [Related]
57. [The diagnosis and treatment of pulmonary hyperhydration in critically ill patients with acute poisoning by neurotropic agents]. Livanov GA; Lodiagin AN; Nikolaeva IP; Batotsyrenov BV Anesteziol Reanimatol; 2008; (6):27-30. PubMed ID: 19227289 [TBL] [Abstract][Full Text] [Related]
58. [Current approaches to cerebroprotective treatment of premature newborns in reanimation and intensive care departments]. Rogatkin SO; Volodin NN; Degtiareva MG; Grebennikova OV; Marganiia MSh; Serova ND Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(1):27-32. PubMed ID: 21350408 [TBL] [Abstract][Full Text] [Related]
59. Early predictive blood markers of hemorrhagic stroke - influence of cytoflavin therapy. Silina EV; Rumyantceva SA; Stupin VA; Parfenov VA; Bolevich SB Can J Physiol Pharmacol; 2021 Jan; 99(1):72-79. PubMed ID: 32910863 [TBL] [Abstract][Full Text] [Related]
60. [The diagnostics of adaptive reactions of blood on application the stress-modulating therapy in patients with brain chronic ischemia]. Krylov VN; Deriugina AV; Antipenko EA; Zakharova OA Klin Lab Diagn; 2012 Dec; (12):25-7. PubMed ID: 23479969 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]